ArticleDiabetology & metabolic syndrome2026
Prediabetes and diabetes exacerbated cardiac systolic function in obese patients at the subclinical stage: insights from global longitudinal strain and myocardial work.
Article in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aimsThis investigation aims to estimate the diagnostic value of global longitudinal strain (GLS) and myocardial work (MW) indices for the identification of subclinical left ventricular (LV) systolic impairment (SLVSI) in individuals with simple obesity, obesity and prediabetes, and obesity and type 2 diabetes mellitus (T2DM).
methodsThis investigation included 302 participants: 225 obese patients and 77 healthy individuals. LV GLS and MW-derived values, namely, the global constructive work (GCW), global work index (GWI), global wasted work (GWW), and global work efficiency (GWE), were analyzed. All individuals with obesity were classified into three groups: simple obesity, individuals with obesity and prediabetes, and individuals with obesity and T2DM. Comparisons of the LV GLS and MW were conducted among the four groups. The independent factors that affected the SLVSI in individuals with obesity were assessed using a logistic regression model. We conducted an ROC analysis to estimate the performance of MW in detecting SLVSI in individuals with obesity.
resultsSignificant differences were detected in the GWI, GCW, LV GLS, GWW, and GWE among normal controls, individuals with simple obesity, individuals with obesity and prediabetes, and individuals with obesity and T2DM (P < 0.05). The combination of the GCW, GWW, GWI, and GWE resulted in the best AUC (0.896) for the determination of SLVSI in individuals with obesity. After adjustment for confounders, prediabetes or T2DM was independently associated with an absolute LV GLS < 20% in obese individuals.
conclusionsIt is feasible to use LV GLS and MW-related parameters to determine SLVSI in individuals with obesity, individuals with obesity and prediabetes, and individuals with obesity and T2DM. Even in the preclinical stage prior to the onset of diabetes, prediabetes still has an incremental effect on SLVSI in obese patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.